跳转至内容
Merck
CN

347R-2

Vimentin (EP21) Rabbit Monoclonal Primary Antibody

登录 查看组织和合同定价。

选择尺寸

变更视图

关于此项目

UNSPSC Code:
12352203
Conjugate:
unconjugated
Clone:
EP21, monoclonal
Application:
IHC (p)
Citations:
4
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助


biological source

rabbit

Quality Level

conjugate

unconjugated

antibody form

culture supernatant

antibody product type

primary antibodies

clone

EP21, monoclonal

description

For In Vitro Diagnostic Use in Select Regions

form

buffered aqueous solution

species reactivity

human

packaging

vial of 0.1 mL concentrate (347R-24), vial of 0.1 mL concentrate Research Use Only (347R-24-RUO), vial of 0.5 mL concentrate (347R-25), vial of 1.0 mL concentrate (347R-26), vial of 1.0 mL concentrate Research Use Only (347R-26-RUO), vial of 1.0 mL pre-dilute Research Use Only (347R-27-RUO), vial of 1.0 mL pre-dilute ready-to-use (347R-27), vial of 7.0 mL pre-dilute ready-to-use (347R-28), vial of 7.0 mL pre-dilute ready-to-use Research Use Only (347R-28-RUO)

manufacturer/tradename

Cell Marque®

technique(s)

immunohistochemistry (formalin-fixed, paraffin-embedded sections): 1:50-1:200 (concentrated)

isotype

IgG

control

tonsil

shipped in

wet ice

storage temp.

2-8°C

visualization

cytoplasmic

Gene Information

human ... VIM(7431)

General description

Anti-vimentin recognizes a 57-kDa intermediate filament initially isolated from mouse fibroblast culture. Anti-vimentin often serves as a useful control marker to ensure that the tissue has been properly preserved and processed. Expression of vimentin, when used in conjunction with keratin, is helpful when distinguishing melanomas from undifferentiated carcinomas and large cell lymphomas. All melanomas and schwannomas react strongly with vimentin. It labels a variety of mesenchymal cells, including melanocytes, lymphocytes, endothelial cells, and fibroblasts. In the area of gynecologic tumors, uterine endometrioid adenocarcinomas display a highly characteristic immunophenotype, with coexpression of low molecular wt. cytokeratin and vimentin.

Physical form

Solution in Tris Buffer, pH 7.3-7.7, with 1% BSA and <0.1% Sodium Azide.

Preparation Note

Download the IFU specific to your product lot and format
Note: This requires a keycode which can be found on your packaging or product label.

Download the latest released IFU
Note: This IFU may not apply to your specific product lot.

Analysis Note


IVD

IVD

IVD

RUO

Other Notes

For Technical Service please contact: 800-665-7284 or email: service@cellmarque.com
Vimentin Positive Control Slides, Product No. 347S, are available for immunohistochemistry (formalin-fixed, paraffin-embedded sections).

Legal Information

Cell Marque is a registered trademark of Merck KGaA, Darmstadt, Germany


Still not finding the right product?

试用我们的 产品选型工具 工具缩小选择范围


存储类别

12 - Non Combustible Liquids

wgk

WGK 2

法规信息

监管及禁止进口产品

此项目有



历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

没有发现合适的版本?

如果您需要特殊版本,可通过批号或批次号查找具体证书。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库



Diagnostic Immunohistochemistry (Masson Publishing) (2010)
D J Dabbs et al.
Human pathology, 27(2), 172-177 (1996-02-01)
Carcinomas of endometrioid histology frequently arise in the endometrium, ovary, and endocervix and involve the pelvic tissues in women. Adenocarcinomas of psuedoendometrioid morphology developing in the colon also frequently involve the ovary. The authors retrospectively examined 97 adenocarcinomas from the
D J Dabbs et al.
The American journal of surgical pathology, 10(8), 568-576 (1986-08-01)
We examined the distribution of high- and low-molecular-weight cytokeratins, vimentin, and carcinoembryonic antigen (CEA) in normal endometrial glands and endocervical glands (20 cases each) and in endometrial and endocervical adenocarcinomas (29 cases and 15 cases respectively). Low- and high-molecular-weight cytokeratin